OXFORDSHIRE, U.K.–(BUSINESS WIRE)– Lombard Medical, Inc. (Nasdaq: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today announced that it has notified Nasdaq of its intention to voluntarily delist the Company’s shares from the Nasdaq Capital Market (“Nasdaq”) and transfer its listing to the OTCQX. Lombard […]
Financial
Early-Stage Medtech HighLife Nabs $14M for Transcatheter Mitral Valve Replacement
PARIS–(BUSINESS WIRE)– HighLife, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the closing of a €12.3 million investment round led by Sofinnova Partners which becomes the main investor in the company. HighLife had previously secured financing from […]
Boston Scientific Announces Results For Third Quarter 2017
MARLBOROUGH, Mass., Oct. 26, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.222 billion during the third quarter ended September 30, 2017. This represents growth of 5.6 percent on a reported basis and 5.7 percent on an operational basis (excludes the impact of changes in foreign currency exchange rates), all compared to the […]
Gore Recognized as one of the World’s Best Workplaces by Great Place to Work®
NEWARK, Del., Oct. 26, 2017 /PRNewswire/ — More than 10 million people from 6,600 companies participated in the survey process for the World’s Best Workplaces list, sharing their perspectives on their work environment. And for the sixth consecutive year, W. L. Gore & Associates is among just 25 companies to earn a spot on the […]
Bard Announces Third Quarter Results And Supplemental Financial Data
MURRAY HILL, N.J.–(BUSINESS WIRE)– C.R. Bard (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial data on its website related to this earnings release. Third quarter 2017 net sales were $989.8 million, an increase of 5 percent over the prior-year period on an as-reported basis. Excluding the […]
Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.7 million were flat versus first quarter last year Gross margin increased to 81.5% from 81.0% in the prior-year period Net loss was $(2.0) […]
Corindus Vascular Robotics to Report Third Quarter 2017 Financial Results on November 7, 2017
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release financial and business results for the second quarter of 2017 after the close of trading on Tuesday, November 7, 2017. The Company’s management team will host a corresponding conference call beginning […]
Gottlieb updates on Puerto Rico med device manufacturing recovery
Gottlieb updates on Puerto Rico med device manufacturing recovery OCTOBER 20, 2017 BY SARAH FAULKNER In the weeks following Hurricanes Irma and Maria, the people and leadership in Puerto Rico have been working to rebuild the island’s infrastructure. The FDA, which has been working with federal and local agencies, today provided an […]
Bay Area’s Claret Medical Nabs $14.5M
SANTA ROSA, Calif.–(BUSINESS WIRE)– Claret Medical, developer of the Sentinel® Cerebral Protection System, the first FDA-cleared cerebral protection device for transcatheter aortic valve replacement (TAVR), today announced that it has closed on a Series C financing of $14.5 million led by Lightstone Ventures, with participation from existing investors Easton Capital, HealthCor Partners, […]
BD Statement On European Commission Conditional Clearance Of Bard Acquisition
FRANKLIN LAKES, N.J., Oct. 18, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s clearance by the European Commission for BD to acquire C.R. Bard (NYSE: BCR), contingent on BD divesting its soft tissue core needle biopsy product line: “We […]



